Most ophthalmology marketing is sold the same way regardless of who’s buying it: an agency or vendor will happily sell the identical SEO package, ad strategy, or content program to every practice in a given city, including direct competitors. There’s no exclusivity built in — if your competitor down the street wants the same service, nothing stops them from buying it too, and now you’re both paying to compete against each other using the same playbook.

An exclusive-per-market model works differently. Once one practice in a defined geographic area licenses it, no competing practice in that same market can access it — full stop, regardless of budget. That single structural difference changes the economics of the program for the practice that gets there first.

Exclusivity matters because it removes one specific kind of competition permanently, not just temporarily. A standard ad campaign or SEO strategy gets less effective the moment a competitor copies it. An exclusive program doesn’t have that decay built in — the advantage compounds the longer you hold it, because no one else in your market is allowed to build the same audience relationship you’re building.

The honest way to evaluate any exclusivity claim is to ask a few direct questions: Is the exclusivity geographic, and how is that geography defined — by city, by zip code, by drive-time radius? Is it enforced contractually, or is it just a marketing claim with no actual mechanism behind it? And critically, how many markets has the program already been licensed in, and is yours still genuinely open?

A program worth taking seriously should be able to answer all three clearly, without vague language. If a vendor can’t tell you exactly what geography is protected and how that protection is enforced, the “exclusive” claim is probably just a sales line — and the real question worth asking is whether your market is still available, or whether someone else already locked it down.